dehydroepiandrosterone has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gefitinib treatment significantly suppressed androgen levels, especially in women who had no smoking history." | 2.71 | Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients. ( Horai, T; Horiike, A; Ishikawa, Y; Nakagawa, K; Nishio, K; Nishio, M; Ohyanagi, F; Okumura, S; Satoh, Y, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishio, M | 1 |
| Ohyanagi, F | 1 |
| Horiike, A | 1 |
| Ishikawa, Y | 1 |
| Satoh, Y | 1 |
| Okumura, S | 1 |
| Nakagawa, K | 1 |
| Nishio, K | 1 |
| Horai, T | 1 |
1 trial available for dehydroepiandrosterone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dehydroepiand | 2005 |